Vancouver
Canada
7
2017-03-23
5
2016-05-03
These are the the leading inventors for applications assigned to ONCOGENEX TECHNOLOGIES INC.:
ONCOGENEX TECHNOLOGIES INC. based in Vancouver, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Method for Selecting Patient Subpopulation for Custirsen Treatment
#2 | 2015-05-07 ✅ Patent 9,326,993 granted on 2016-05-03Treatment of pulmonary and pleural fibrosis using HSP27 inhibitors
#3 | 2014-09-18 ✅ Patent 9,359,606 granted on 2016-06-07Anti-clusterin monotherapy for cancer treatment
#4 | 2014-09-18 ✅ Patent 9,364,496 granted on 2016-06-14Custirsen treatment with reduced toxicity
#5 | 2013-05-23Antisense Formulation
#6 | 2012-11-22 ✅ Patent 8,987,223 granted on 2015-03-24Treatment of pulmonary and pleural fibrosis using HSP27 inhibitors
#7 | 2011-04-28 ✅ Patent 8,383,336 granted on 2013-02-26Antisense formulation
Also check out ONCOGENEX TECHNOLOGIES INC.'s (Vancouver, Canada) applicant profile with 3 patent applications submitted.
24272 ⎘